Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James A Talbot

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Antimicrobial Agents and Chemotherapy|September 18, 2002
Comparative evaluation of a new fluorescent carboxyfluorescein diacetate-modified microdilution method for antifungal susceptibility testing of Candida albicans isolatesRobert S Liao, Robert P Rennie, James A Talbot
Neurology|April 17, 2008
Sexual function in men with epilepsy: how important is testosterone?James A Talbot, Russell Sheldrick, Helen Caswell, et al.
Antimicrobial Agents and Chemotherapy|March 26, 2003
Sublethal injury and resuscitation of Candida albicans after amphotericin B treatmentRobert S Liao, Robert P Rennie, James A Talbot
Emerging Infectious Diseases|May 9, 2002
Outbreak of Neisseria meningitidis, Edmonton, Alberta, CanadaGregory J Tyrrell, Linda Chui, Marcia Johnson, et al.
Journal of Clinical Microbiology|November 28, 2002
M types of group a streptococcal isolates submitted to the National Centre for Streptococcus (Canada) from 1993 to 1999Gregory J Tyrrell, Marguerite Lovgren, Betty Forwick, et al.
Diagnostic Microbiology and Infectious Disease|February 1, 2002
Susceptibility of human isolates of Salmonella typhimurium DT 104 to antimicrobial agents used in human and veterinary medicineBrenda A Beaudin, Cheryl A Brosnikoff, Karen M Grimsrud, et al.
Journal of Clinical Microbiology|August 10, 2007
Evolution of an international external quality assurance model to support laboratory investigation of Streptococcus pneumoniae, developed for the SIREVA project in Latin America, from 1993 to 2005Marguerite Lovgren, James A Talbot, Maria Cristina Brandileone, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Antimicrobial Agents and Chemotherapy|September 18, 2002
Comparative evaluation of a new fluorescent carboxyfluorescein diacetate-modified microdilution method for antifungal susceptibility testing of Candida albicans isolatesRobert S Liao, Robert P Rennie, James A Talbot
Neurology|April 17, 2008
Sexual function in men with epilepsy: how important is testosterone?James A Talbot, Russell Sheldrick, Helen Caswell, et al.
Antimicrobial Agents and Chemotherapy|March 26, 2003
Sublethal injury and resuscitation of Candida albicans after amphotericin B treatmentRobert S Liao, Robert P Rennie, James A Talbot
Emerging Infectious Diseases|May 9, 2002
Outbreak of Neisseria meningitidis, Edmonton, Alberta, CanadaGregory J Tyrrell, Linda Chui, Marcia Johnson, et al.
Journal of Clinical Microbiology|November 28, 2002
M types of group a streptococcal isolates submitted to the National Centre for Streptococcus (Canada) from 1993 to 1999Gregory J Tyrrell, Marguerite Lovgren, Betty Forwick, et al.
Diagnostic Microbiology and Infectious Disease|February 1, 2002
Susceptibility of human isolates of Salmonella typhimurium DT 104 to antimicrobial agents used in human and veterinary medicineBrenda A Beaudin, Cheryl A Brosnikoff, Karen M Grimsrud, et al.
Journal of Clinical Microbiology|August 10, 2007
Evolution of an international external quality assurance model to support laboratory investigation of Streptococcus pneumoniae, developed for the SIREVA project in Latin America, from 1993 to 2005Marguerite Lovgren, James A Talbot, Maria Cristina Brandileone, et al.
Pageof 1